IP Library Granted Patent US 10,214,737
Granted Patent B2
US 10,214,737 · App. 15/865,757 · Granted Feb 26, 2019

Thermophilic and thermoacidophilic metabolism genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods

Inventors: Vicki S. Thompson (Idaho Falls, ID); William A. Apel (Jackson, WY); Jeffrey A. Lacey (Idaho Falls, ID); Brady D. Lee (West Richland, WA); David W. Reed (Idaho Falls, ID); Francisco F. Roberto (Highlands Ranch, CO); David N. Thompson (Idaho Falls, ID)
Assignee: Battell Energy Alliance, LLC
C12N9/88C12N9/00C12N9/1029C12N15/74C12N15/75C12Y402/01055C12Y203/01009
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,214,737
App. No.
15/865,757
Granted
Feb 26, 2019
Kind
B2
Abstract

Isolated and/or purified polypeptides and nucleic acid sequences encoding polypeptides from Alicyclobacillus acidocaldarius are provided. Further provided are methods for modulating or altering metabolism in a cell using isolated and/or purified polypeptides and nucleic acid sequences from Alicyclobacillus acidocaldarius.

Claims (9)

1. An expression vector comprising an isolated polynucleotide encoding a polypeptide having at least 90% sequence identity to SEQ ID No. 426 and a nucleotide sequence heterologous to the polynucleotide.

2. The expression vector of claim 1 , wherein the expression vector comprises an isolated polynucleotide having at least 95% identity to SEQ ID No. 427.

3. The expression vector of claim 1 , wherein the encoded polypeptide has Butyryl-CoA dehydrogenase enzymatic activity.

4. A method of modulating or altering metabolism in a cell, the method comprising:

providing the expression vector of claim 3 to the cell and expressing the encoded polypeptide in the cell.

5. The method according to claim 4 , further comprising glycosylating, or otherwise post-translationally modifying the encoded peptide in the cell.

6. An expression vector comprising an isolated polynucleotide encoding a polypeptide having at least 95% sequence identity to SEQ ID No. 426 and a nucleotide sequence heterologous to the polynucleotide.

7. The expression vector of claim 6 , wherein the encoded polypeptide has Butyryl-CoA dehydrogenase enzymatic activity.

8. The expression vector of claim 6 , wherein the expression vector comprises an isolated polynucleotide having at least 95% identity to SEQ ID No. 427.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jan 15, 2020
From: BATTELLE ENERGY ALLIANCE/IDAHO NAT'L LAB
To: UNITED STATES DEPARTMENT OF ENERGY
Reel/Frame 051990/0051 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2019
From: THOMPSON, VICKI S.; APEL, WILLIAM A.; REED, DAVID W.; LEE, BRADY D.; THOMPSON, DAVID N.; ROBERTO, FRANCISCO F.; LACEY, JEFFREY A.
To: BATTELLE ENERGY ALLIANCE, LLC
Reel/Frame 047990/0029 →
Continuity (6)
Division 15347903 · Nov 10, 2016
Continuation 14887073 · Oct 19, 2015
Division 14226573 · Mar 26, 2014
Division 12380551 · Feb 26, 2009
Provisional Application 61032339 · Feb 28, 2008
Related Publication 20180135037A1 · May 17, 2018